Functional label-free assays for characterizing the in vitro mechanism of action of small molecule modulators of capsid assembly

Biochemistry
Latesh LadNikos Pagratis

Abstract

HIV capsid protein is an important target for antiviral drug design. High-throughput screening campaigns have identified two classes of compounds (PF74 and BI64) that directly target HIV capsid, resulting in antiviral activity against HIV-1 and HIV-2 laboratory strains. Using recombinant proteins, we developed a suite of label-free assays to mechanistically understand how these compounds modulate capsid activity. PF74 preferentially binds to the preassembled hexameric capsid form and prevents disruption of higher-order capsid structures by stabilizing capsid intersubunit interactions. BI64 binds only the monomeric capsid and locks the protein in the assembly incompetent monomeric form by disrupting capsid intersubunit interactions. We also used these assays to characterize the interaction between capsid and the host protein cleavage and polyadenylation specific factor 6 (CPSF6). Consistent with recently published results, our assays revealed CPSF6 activates capsid polymerization and preferentially binds to the preassembled hexameric capsid form similar to the small molecule compound, PF74. Furthermore, these label-free assays provide a robust method for facilitating the identification of a different class of small molecule modu...Continue Reading

References

Sep 1, 1996·Nature Structural Biology·C MomanyM G Rossmann
Jan 5, 1999·Science·B K GanserW I Sundquist
Jan 1, 2003·Journal of Molecular Biology·Jason LanmanPeter E Prevelige
Feb 14, 2004·Journal of Virology·Barbie K Ganser-PornillosWesley I Sundquist
Jun 23, 2004·Nature Structural & Molecular Biology·John A G BriggsMarc C Johnson
Oct 10, 2007·Cell·Barbie K Ganser-PornillosMark Yeager
Jan 13, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Babafemi Taiwo
Jun 16, 2009·Cell·Owen PornillosMark Yeager
Sep 29, 2009·Antiviral Research·Catherine S Adamson, Eric O Freed
Oct 15, 2009·The FEBS Journal·Anjali P Mascarenhas, Karin Musier-Forsyth
Oct 30, 2009·Molecular Biology of the Cell·Marc-David RueppSilvia M L Barabino
Mar 17, 2010·Cell Host & Microbe·KyeongEun LeeVineet N KewalRamani
Dec 21, 2010·PLoS Pathogens·Wade S BlairScott L Butler
Jan 21, 2011·Nature·Owen PornillosMark Yeager
Jul 19, 2011·Journal of Molecular Biology·Peter E Prevelige
Sep 8, 2012·PLoS Pathogens·Amanda J PriceLeo C James
Jul 26, 2013·Journal of Virology·Thomas FrickeFelipe Diaz-Griffero
Dec 19, 2014·Proceedings of the National Academy of Sciences of the United States of America·Akash BhattacharyaMark Yeager

❮ Previous
Next ❯

Citations

May 22, 2018·Current Opinion in HIV and AIDS·Stephanie K CarnesChristopher Aiken
Jun 3, 2021·Viruses·Maryam TabasiZeger Debyser
Jun 28, 2019·Journal of the American Chemical Society·Alexander J PakGregory A Voth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.